Research Topic: pharmaceutical pollution

Editorial: Pharmaceutically active micropollutants – how serious is the problem and is there a microbial way out?

mycolabadmin

Medicines we take don’t fully disappear—30 to 90% are excreted unchanged and end up in water supplies. These pharmaceutical residues contaminate drinking water and harm aquatic life worldwide. Scientists are discovering that certain fungi and bacteria can break down these drug residues through natural metabolic processes. By harnessing these microbes in treatment systems and improving waste management practices, we could significantly reduce pharmaceutical pollution.

Read More »

The potential of fungi in the bioremediation of pharmaceutically active compounds: a comprehensive review

mycolabadmin

Pharmaceutical drugs that we take end up in our water systems because our bodies don’t fully process them. Fungi, especially types of mushrooms, have powerful enzymes that can break down these drug residues and clean contaminated water. Scientists are studying how to use these fungi in treatment systems to remove medications from hospital wastewater and drinking water sources.

Read More »

Pharmaceutical Pollution in Aquatic Environments: A Concise Review of Environmental Impacts and Bioremediation Systems

mycolabadmin

Medications we take for health are ending up in our water supplies in significant amounts because standard water treatment plants cannot remove them effectively. These pharmaceutical residues are harming wildlife and aquatic ecosystems, causing problems like population declines in birds, developmental issues in fish, and the spread of antibiotic resistance. Scientists are developing new bioremediation technologies, particularly using fungi and mycoremediation, to better remove these drugs from wastewater before they reach our water bodies.

Read More »
Scroll to Top